GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Haohai Biological Technology Co Ltd (HKSE:06826) » Definitions » Tax Rate %

Shanghai Haohai Biological Technology Co (HKSE:06826) Tax Rate % : 20.67% (As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Shanghai Haohai Biological Technology Co Tax Rate %?

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Shanghai Haohai Biological Technology Co's Tax Expense for the three months ended in Sep. 2024 was HK$28 Mil. Shanghai Haohai Biological Technology Co's Pre-Tax Income for the three months ended in Sep. 2024 was HK$136 Mil. Therefore, Shanghai Haohai Biological Technology Co's Tax Rate % for the quarter that ended in Sep. 2024 was 20.67%.

Shanghai Haohai Biological Technology Co Tax Rate % Historical Data

The historical data trend for Shanghai Haohai Biological Technology Co's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Haohai Biological Technology Co Tax Rate % Chart

Shanghai Haohai Biological Technology Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Tax Rate %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.94 9.24 19.26 18.89 19.29

Shanghai Haohai Biological Technology Co Quarterly Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Tax Rate % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.26 18.99 15.61 20.67 24.40

Shanghai Haohai Biological Technology Co Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Shanghai Haohai Biological Technology Co's Tax Rate % for the fiscal year that ended in Dec. 2023 is calculated as

Tax Rate %=Tax Expense (A: Dec. 2023 )/Pre-Tax Income (A: Dec. 2023 )
=104.993/555.924
=18.89 %

Shanghai Haohai Biological Technology Co's Tax Rate % for the quarter that ended in Sep. 2024 is calculated as

Tax Rate %=Tax Expense (Q: Sep. 2024 )/Pre-Tax Income (Q: Sep. 2024 )
=28.213/136.472
=20.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Haohai Biological Technology Co Tax Rate % Related Terms

Thank you for viewing the detailed overview of Shanghai Haohai Biological Technology Co's Tax Rate % provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Haohai Biological Technology Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Haohai Biological Technology Co Ltd (HKSE:06826) » Definitions » Tax Rate %
Comparable Companies
HKSE:06855 HKSE:09995 HKSE:01952 HKSE:02696 HKSE:02410 HKSE:09969 HKSE:02162 HKSE:01530 HKSE:02171 HKSE:06660 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
5HB:Germany 688366:China
Address
No. 1386 Hongqiao Road, 23rd Floor, WenGuang Plaza, Changning District, Shanghai, CHN
Website
https://www.3healthcare.com
Shanghai Haohai Biological Technology Co Ltd is engaged in the manufacturing and sale of biologicals, medical hyaluronate, and ophthalmology products. The Company's operating activities are related to single operating segment which is the manufacture and sale of biologicals, medical hyaluronate and intraocular lens, research and development of biological engineering and pharmaceutical products and the provision of related services. Its products are categorized into four types comprising ophthalmology, medical aesthetics, orthopedics, and anti-adhesion. Geographically, it has operations in Mainland China which is the key revenue driver, the United States, the United Kingdom, and other countries.
Executives
Morgan Stanley 2201 Interest of corporation controlled by you
Dalton Investments Llc 2102 Investment manager
The Bank Of New York Mellon Corporation 2201 Interest of corporation controlled by you
Templeton Investment Counsel, Llc 2102 Investment manager
Kabouter Management Llc 2102 Investment manager
Royal Bank Of Canada 2201 Interest of corporation controlled by you
Kabouter International Insight Fund, Llc 2102 Investment manager
Prudence Investment Management (hong Kong) Limited 2102 Investment manager

Shanghai Haohai Biological Technology Co Headlines

No Headlines